These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8111303)

  • 41. Quantum chemical methods for the investigation of photoinitiated processes in biological systems: theory and applications.
    Dreuw A
    Chemphyschem; 2006 Nov; 7(11):2259-74. PubMed ID: 17009357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in and limitations of up-and-down methodology: a précis of clinical use, study design, and dose estimation in anesthesia research.
    Pace NL; Stylianou MP
    Anesthesiology; 2007 Jul; 107(1):144-52. PubMed ID: 17585226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new polyalgorithmic method for time-course analysis of pharmacological data describable by a multiexponential function [proceedings].
    Gomeni C; Gomeni R
    Br J Pharmacol; 1978 Jun; 63(2):399P. PubMed ID: 667473
    [No Abstract]   [Full Text] [Related]  

  • 44. PET and drug research and development.
    Fowler JS; Volkow ND; Wang GJ; Ding YS; Dewey SL
    J Nucl Med; 1999 Jul; 40(7):1154-63. PubMed ID: 10405137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo.
    Jonker DM; Visser SA; van der Graaf PH; Voskuyl RA; Danhof M
    Pharmacol Ther; 2005 Apr; 106(1):1-18. PubMed ID: 15781119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of the muscarinic receptors in the pathogenesis of the convulsive state induced by korazol in rats].
    Khobotova ZI; Mukovskiĭ LA; Kosmachev AB; Fil'ko OA; Filippov VN; Dolgo-Saburov VB
    Eksp Klin Farmakol; 1997; 60(1):16-8. PubMed ID: 9162273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm.
    Breimer DD; Danhof M
    Clin Pharmacokinet; 1997 Apr; 32(4):259-67. PubMed ID: 9113436
    [No Abstract]   [Full Text] [Related]  

  • 48. Threshold Dose--Response Model--RIP: 1911 to 2006.
    Calabrese EJ
    Bioessays; 2007 Jul; 29(7):686-8. PubMed ID: 17563088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of combined drug action].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1992 Jul; 23(3):248-53. PubMed ID: 1299964
    [No Abstract]   [Full Text] [Related]  

  • 50. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
    Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
    IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical mixture toxicity testing with Vibrio fischeri: combined effects of binary mixtures for ten soft electrophiles.
    Dawson DA; Pöch G; Schultz TW
    Ecotoxicol Environ Saf; 2006 Oct; 65(2):171-80. PubMed ID: 16139365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A quasistationary analysis of a stochastic chemical reaction: Keizer's paradox.
    Vellela M; Qian H
    Bull Math Biol; 2007 Jul; 69(5):1727-46. PubMed ID: 17318672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Researching with, rather than researching for...an introduction to qualitative methods in nursing research].
    Rousseau N; Saillant F
    Rech Soins Infirm; 1996 Jun; (45):138-46. PubMed ID: 16737021
    [No Abstract]   [Full Text] [Related]  

  • 54. Protein models in drug discovery.
    Norin M; Sundström M
    Curr Opin Drug Discov Devel; 2001 May; 4(3):284-90. PubMed ID: 11560059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses.
    Fang HB; Ross DD; Sausville E; Tan M
    Stat Med; 2008 Jul; 27(16):3071-83. PubMed ID: 18186545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of experimental design methodology in development and optimization of drug release method.
    Kincl M; Turk S; Vrecer F
    Int J Pharm; 2005 Mar; 291(1-2):39-49. PubMed ID: 15707730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Animal tests and human health.
    Bates R
    FDA Consum; 1977 Sep; 11(7):12-5. PubMed ID: 10304998
    [No Abstract]   [Full Text] [Related]  

  • 58. Factorial design approach to evaluate interactions between electrically assisted enhancement and skin stripping for delivery of tacrine.
    Hirsch AC; Upasani RS; Banga AK
    J Control Release; 2005 Mar; 103(1):113-21. PubMed ID: 15710505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug interaction studies: study design, data analysis, and implications for dosing and labeling.
    Huang SM; Temple R; Throckmorton DC; Lesko LJ
    Clin Pharmacol Ther; 2007 Feb; 81(2):298-304. PubMed ID: 17259955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.